Related Experiment Videos

[Chronic complication of diabetes and homocysteine]

B Idzior-Waluś1, G Cieślik

  • 1Katedra Chorób Metabolicznych Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.

Przeglad Lekarski
|June 12, 2001
PubMed

Insights

High homocysteine levels increase cardiovascular disease risk, especially in diabetics. Further research is needed to clarify its role in diabetic microvascular complications for better prevention strategies.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Metabolic Diseases

Context:

  • Elevated homocysteine is linked to cardiovascular disease (CVD) incidence and mortality.
  • Diabetics with hyperhomocysteinemia face even greater CVD risks.
  • Mechanisms include procoagulant activity, oxidative stress, and smooth muscle cell proliferation.

Purpose:

  • To investigate the role of hyperhomocysteinemia in microvascular complications of diabetes.
  • To explore the relationship between homocysteine levels and diabetic retinopathy, neuropathy, and albuminuria.
  • To assess the potential for modifying homocysteine levels in diabetes prevention and management.

Summary:

  • Hyperhomocysteinemia is a risk factor for cardiovascular disease, particularly in individuals with diabetes mellitus.
  • While its role in macrovascular complications is established, its impact on microvascular complications like retinopathy, neuropathy, and albuminuria is debated.
  • Homocysteine levels are influenced by age, renal function, and B vitamin/folic acid intake, with insulin's role also under investigation.

Impact:

  • Clarifying hyperhomocysteinemia's role in microvascular complications can guide preventative strategies.
  • Understanding these mechanisms may lead to novel dietary and pharmacological interventions for diabetes management.
  • This research could improve prevention of both macrovascular and microvascular complications in diabetic patients.

Related Concept Videos